Plasmapheresis Therapy in Macroglobulinemia

Article1 May 1963Plasmapheresis Therapy in MacroglobulinemiaALAN SOLOMON, M.D., JOHN L. FAHEY, M.D.ALAN SOLOMON, M.D.Search for more papers by this author, JOHN L. FAHEY, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-58-5-789 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptDeath or disability of a patient with malignant disease may result from direct growth of the tumor or from the elaboration of some harmful product. In the latter instance it should be possible to alter the disease course by modification or removal of the offending substance. At the present time, however, there are a few situations where a deleterious substance present in an excessive amount can be removed in a practicable way. In polycythemia vera, reduction of red blood cell mass by removal of whole blood is a standard form of therapy (1). In primary (Waldenström's) macroglobulinemia, removal of the...References1. DAMESHEK W: Editorial. The treatment of polycythemia. Blood 1: 256, 1946. CrossrefGoogle Scholar2. SKOOGADAMS WAWS: Plasmapheresis in case of Waldenström's macroglobulinemia. Clin. Research 7: 96, 1959. Google Scholar3. SKOOGADAMSCOBURN WAWSJW: Metabolic balance study of plasmapheresis in a case of Waldenström's macroglobulinemia. Blood 29: 425, 1962. CrossrefGoogle Scholar4. SCHWABFAHEY PJJL: Treatment of Waldenström's macroglobulinemia by plasmapheresis. New Engl. J. Med. 263: 574, 1960. CrossrefMedlineGoogle Scholar5. FAHEY JL: Studies of anomalous γ, -β2A-and γ1-macroglobulins. J. Biol. Chem. 237: 440, 1962. CrossrefMedlineGoogle Scholar6. FAHEYBOGGS JLDR: Serum protein changes in malignant diseases. I. the acute leukemias. Blood 16: 1479, 1960. CrossrefMedlineGoogle Scholar7. SCHWABOKUNFAHEY PJEJL: Reversal of retinopathy in Waldenström's macroglobulinemia by plasmapheresis. Arch. Ophthal. (Chicago) 64: 515, 1960. CrossrefMedlineGoogle Scholar8. KLIMANGAYDOSSCHROEDERFREIREICH ALALREJ: Repeated plasmapheresis of blood donors as a source of platelets. Blood 18: 303, 1961. CrossrefMedlineGoogle Scholar9. CLINESOLOMONBERLINFAHEY MJANIJL: Anemia in macroglobulinemia. Amer. J. Med. 34: 213, 1963. CrossrefMedlineGoogle Scholar10. STERLING K: The turnover rate of serum albumin in man as measured by I131-tagged albumin. J. Clin. Invest. 30: 1228, 1951. CrossrefMedlineGoogle Scholar11. GITLINJANEWAYFARR DCALE: Studies on the metabolism of plasma proteins in the nephrotic syndrome. I. Albumin, γ-globulin and iron-binding globulin. J. Clin. Invest. 35: 44, 1956. CrossrefMedlineGoogle Scholar12. SOLOMONWALDMANNFAHEY ATJL: Metabolism of normal 6.6 S γ-globulin in normal subjects and in patients with macroglobulinemia and multiple myeloma. J. Lab. Clin. Med. In press. Google Scholar13. COHENFREEMAN ST: Metabolic heterogeneity of human γ-globulin. Biochem. J. 76: 475, 1960. CrossrefMedlineGoogle Scholar14. WALDENSTRÖM J: Incipient myelomatosis or "essential" hyperglobulinemia with fibrinogenopenia—a new syndrome? Acta Med. Scand. 117: 216, 1944. CrossrefGoogle Scholar15. WALDENSTRÖM J: Die Makroglobulinamie. Ergben. Inn Med. Kinderheilk. 9: 591, 1958. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Bethesda, MarylandFrom the Metabolism Service, National Cancer Institute, National Institutes of Health, United States Public Health Service, Department of Health, Education, and Welfare, Bethesda 14, Maryland.This paper was presented at the Forty-third Annual Session of the American College of Physicians, Philadelphia, Pennsylvania, April 9-13, 1962.Requests for reprints should be addressed to John L. Fahey, M.D., Metabolism Service, National Cancer Institute, National Institutes of Health, Bethesda 14, Maryland. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byBasic principles of therapeutic plasma exchangeCryoglobulinemia and double‐filtration plasmapheresis: Personal experience and literature reviewTherapeutic Plasma Exchange and Immunoadsorption: Indications and ImplementationPlasmapheresis in Acute Intoxication and PoisoningMembrane-based therapeutic plasma exchange (mTPE): Technical and clinical experienceÉchanges plasmatiques en néphrologie : techniques et indicationsHyperviscosity Syndrome, Cold Agglutinin Hemolytic Anemia, and CryoglobulinemiaSyndrome d’hyperviscosité plasmatiqueApheresis nursing: A Canadian perspectiveTherapeutic Apheresis for Patients with CancerA Stepwise Approach for the Management of Poisoning with Extracorporeal TreatmentsAvailable Extracorporeal Treatments for Poisoning: Overview and LimitationsRole of therapeutic apheresis and phlebotomy techniques in anaesthesia and critical careExchange Transfusion and HaemapheresisRole of Plasmapheresis in Waldenström's MacroglobulinemiaTherapeutic Cytapheresis, Plasmapheresis, and Plasma Exchange in Neoplastic Diseases of the BloodÉchanges plasmatiques en néphrologie : techniques et indicationsEvidence-based focused review of management of hyperviscosity syndromeGuidelines on the use of therapeutic apheresis in clinical practice-Evidence-based approach from the apheresis applications committee of the American Society for ApheresisWaldenström's Macroglobulinemia: Hyperviscosity Syndrome and CryoglobulinemiaIgM Turnover in ManSelective Leukocyte Apheresis for the Treatment of Inflammatory Bowel DiseaseGuidelines on the use of therapeutic apheresis in clinical practice—Evidence-based approach from the apheresis applications committee of the American society for apheresisTherapeutic Apheresis: Basic Principles and Practical AspectsTherapeutic Apheresis for the Renal Complications of Multiple Myeloma and the DysglobulinemiasTherapeutic Apheresis for the Renal Complications of Multiple Myeloma and the DysglobulinemiasApheresis for Renal DiseaseHyperviscosity SyndromesPlasmapheresis with a Substitution Solution of Human Serum Protein (5%) Versus Plasmapheresis with a Substitution Solution of Human Albumin (5%) in Patients Suffering from Autoimmune DiseasesImmunological Effects of Therapeutic Immunoadsorption with Respect to BiocompatibilityTherapeutic Plasma Exchange for the Treatment of Rapidly Progressive GlomerulonephritisSpin Doctors: New Innovations for Centrifugal ApheresisIndications for Emergency Apheresis ProceduresPlasmapheresis in the treatment of systemic lupus erythematosusPlasma Exchange for Non-Renal IndicationsClinical Applications of Therapeutic HemapheresisPlasma Exchange in Renal DiseaseHyperviscosity SyndromeWaldenström's macroglobulinemia with an IgM paraprotein that is both a cold agglutinin and a cryoglobulin and has a suppressive effect on progenitor cell growthHemostatic Abnormalities in Multiple Myeloma and Related DisordersHemapheresis in Pregnancy *Neurologic symptoms and complications of monoclonal gammophatiesWaldenström's macroglobulinaemia: results of a combined oral treatment in 34 newly diagnosed patientsTherapeutic approaches in mixed cryoglobulinemiaTREATMENT OF RESISTANT WALDENSTROM'S MACROGLOBULINEMIA WITH HIGH DOSE GLUCOCORTICOSTEROIDSVertigo in the Hyperviscosity SyndromePrevention and treatment of hyperviscosity syndrome4 Rheology of paraproteinaemias and the plasma hyperviscosity syndromeTreatment of Acute Serum Sickness by Plasma UltrafiltratiorEffects of plasmapheresis on peripheral blood mononuclear cell populations from patients with macroglobulinemiaHemorheological treatmentApheresis in Renal Transplantation and Chronic Inflammatory Demyelinating Polyneuropathy: Case Studies in the Evolution of Enthusiasm for a TechnologyLong term treatment of mixed cryoglobulinemia (MCG)Plasma exchange in hands of the neurologistTherapeutic Plasmapheresis and Plasma ExchangeVariations hémorhéologiques au cours de 50 dysglobulinémies monoclonales traitées par échanges plasmatiquesApheresis in Chronic Inflammatory Demyelinating Polyneuropathy and in Renal TransplantationPlasmapheresis in Hyperviscosity SyndromePlasmapheresisAphresisPlasmapheresis and Cold Sensitivity of Immunoglobulin MoleculesMembrane plasma exchange: Principles and application techniquesTherapeutic Apheresis: Applications and Future DirectionsPlasma Exchange: Principles and PracticeWhat Are the Established Clinical Indications for Therapeutic Plasma Exchange and How Important Is the Choice of Replacement Fluid for Efficacy of Therapeutic Plasma Exchange in These Situations?Influence of blood viscosity on cochlear action potentials and oxygenationA New Therapeutic Antibody Removal Method Using Antigen Positive Red Cells: Application to M-Incompatible Pregnant WomenEffect of plasma exchange on blood viscosity and cerebral blood flow.Issues in Therapeutic ApheresisPlasmapheresis in SLETherapeutic HemapheresisPLASMA EXCHANGE IN THE TREATMENT OF SEVERE, CHILDHOOD ONSET SYSTEMIC LUPUS ERYTHEMATOSUSPlasma Exchange and Moderate Dose of Cytostatics in Advanced Macro(cryo)globulinemiaNational center for health care technology assessment of therapeutic apheresis for rheumatoid arthritis, 1981The hemostatic system in children undergoing intensive plasma exchangePlasma Exchange in the Treatment of Immune Complex DiseasePlasma exchange in systemic lupus erythematosus.Plasmapheresis: A pediatric perspectivePlasma ExchangeAdvances in the use of therapeutic pheresis for the management of rheumatic diseasesHyperviscosity syndrome associated with an idiopathic monoclonal IgA-rheumatoid factorBlood rheology.Plasmapheresis-Bloodletting Revived and RefinedMonoclonal Immunoglobulins As Biomarkers Of CancerSuccessful treatment by plasmapheresis of respiratory insufficiency in myasthenia gravisPLASMA EXCHANGE: A SELECTIVE FORM OF BLOOD‐LETTINGTherapeutic Plasmapheresis for Collagen DiseasesBiology, Clinical Patterns, and Treatment of Multiple Myeloma and Related Plasma–Cell DyscrasiasKomplikationen und supportive Therapie der Leukämien und malignen Non-Hodgkin-LymphomePlasmapheresis: Great Economy in the Use of HorsesEffect of plasma exchange on circulating immune complexes and antibody formation in patients treated with cyclophosphamide and prednisoneOtolaryngological disturbances in Waldenstrom's macroglobulinaemiaPLASMAPHERESIS IN MACROGLOBULINÆMIAMultiple Myeloma and Primary Macroglobulinemia (Waldenström)Positional Nystagmus in Association with MacroglobulinemiaKlinik und Therapie des Morbus Waldenström und der H-Ketten-ErkrankungenSjögren's Syndrome: Hyperviscosity and Intermediate ComplexesWILLIAM M. BLAYLOCK, M.D., MARION WALLER, Ph.D., DAVID E. NORMANSELL, Ph.D.Paraproteinämische HämoblastosenErfahrung mit der Procarbazintherapie bei Morbus WaldenströmImmunoglobulin Disturbances and Their Clinical SignificanceCRYOGENIC DISEASESThe Pathology Of Sudden DeafnessAggregation phenomenon in an IgG multiple myeloma resulting in the hyperviscosity syndromePlasmapheresis in Acute Pulmonary EdemaRetinal Circulation in the Hyperviscosity SyndromeSyndromes of HyperviscosityA lambda light chain cold agglutinin-cryomacroglobulin occurring in Waldenström's macroglobulinemiaSafety and Long-term Effects of PlasmapheresisBIBLIOGRAPHYTherapeutic Plasmapheresis in Treatment of Patients with Waldenström's MacroglobulinemiaIntense plasmapheresis in the pregnant Rh-sensitized womanMacroglobulinemia and vasculitis in Sjögren's syndromePrimary macroglobulinemiaM-proteins, plasmacytosis and cancerUltrastructure of the Fibrin ClotThe Treatment of Plasma Cell MyelomaTurnover of 131I-labeled Autologous Macroglobulin in Waldenström's Macroglobulinemia Report of a Case Studied During Treatment with Phenylalanine MustardPATRICIA WILKINSON, M.D., F.R.C.P., WARREN DAVIDSON, M.D., AMORY SOMMARIPA, M.D.Waldenström's macroglobulinemiaREFERENCESAggregation of IgG globulin in vivoDie hämorrhagischen DiathesenMacroglobulinemiaSerum protein disorders causing clinical symptoms in malignant neoplastic disease 1 May 1963Volume 58, Issue 5Page: 789-800KeywordsBlindnessDisabilitiesElectroencephalographyHemorrhageMedical servicesNeurologyOphthalmologyPolycythemia veraPrevention, policy, and public healthRed blood cells ePublished: 1 December 2008 Issue Published: 1 May 1963 PDF downloadLoading ...